SURGLASSES

SURGLASSES, officially registered as Taiwan Main Orthopaedic Biotechnology Co., Ltd., has established itself as a pioneer in augmented reality (AR) and mixed reality (MR) surgical navigation systems. Founded in 2017 and headquartered in Taichung, Taiwan, the company develops smart surgical eyewear that enables surgeons to visualize patient anatomy in real-time during complex orthopedic and neurosurgical procedures.

Company Overview

Dr. Wang Min-Liang founded SURGLASSES with the vision of transforming surgical workflows through AR and MR technologies. The company began developing its core technology in collaboration with key opinion leaders worldwide starting in 2013, eventually launching commercial products after years of clinical validation and regulatory submissions.

SURGLASSES operates manufacturing facilities in Taichung with certifications including CE Mark, ISO 13485, and GMP compliance. The company secured $6.5 million in Pre-A funding in November 2023, with participation from 500 Global, Taiwania Capital Management Corporation, Integrated Capital, Sustainable Impact Capital, and Wisdom Capital.

Core Products

Caduceus S AR Spine Navigation System

The Caduceus S represents SURGLASSES’ flagship surgical navigation product, combining AR and MR technologies specifically designed for complex spine surgeries. The system received TFDA Class II clearance in August 2022, becoming the first surgical AR imaging system approved in Taiwan. FDA 510(k) clearance followed in December 2022.

Caduceus S requires only 2-4 C-arm X-ray images to generate a 3D spinal model that surgeons view through a transparent head-mounted display. Clinical validation demonstrated 98.2% accuracy using the Heary (thoracic) and Gertzbein (lumbar) scales, with positioning precision under 1.5mm.

Foresee-X AR Surgical Glasses

Foresee-X targets the orthopedic trauma market, helping surgeons synchronize intraoperative fluoroscopy images directly in their field of view. The system holds CE certification and FDA registration, with ISO 13485 certification obtained in 2018. Clinical applications include interlocking nail procedures, pelvic surgeries, and wrist operations.

Medical Education Products

Beyond surgical navigation, SURGLASSES develops the Asclepius line of virtual dissection tables for medical education. The Asclepius AI Table, launched in June 2025, features integrated AI instructors for anatomy education.

Technology & Innovation

SURGLASSES holds patents enabling precise navigation with single C-arm imaging, reducing radiation exposure compared to traditional navigation methods. The company’s transparent head-mounted display design maintains 100% surgeon field of view while projecting preoperative trajectories and anatomical overlays.

Key technical advantages include real-time X-ray image display, 3D model superimposition onto patient anatomy, and trajectory guidance for screw placement without requiring surgeons to look away from the operative field.

Clinical Milestones

• October 2022: First-in-human Caduceus S surgery performed in Taiwan for a scoliosis case with 58° curvature
• April 2023: First AR-assisted spine surgery completed in the United States
• 2023-Present: Commercial deployment across Taiwan hospitals with expansion into US market

Market Presence

SURGLASSES has established partnerships with hospitals in Taiwan and Malaysia, including specialized trauma centers utilizing Foresee-X technology. The company positions its products as cost-effective alternatives to traditional navigation systems, particularly suited for small and medium-sized hospitals with limited resources.

Frequently Asked Questions

What regulatory approvals does SURGLASSES have?

Caduceus S holds both TFDA Class II clearance (August 2022) and FDA 510(k) clearance (December 2022). Foresee-X is CE certified and FDA registered. The company maintains ISO 13485 and GMP certifications for its manufacturing operations.

What surgeries can SURGLASSES products support?

Caduceus S is designed for complex spine surgeries including pedicle screw placement. Foresee-X supports orthopedic trauma procedures including interlocking nail placement, pelvic fracture fixation, and wrist surgery.

How does AR navigation improve surgical outcomes?

Clinical data from Caduceus S shows 98.2% accuracy in screw placement. The technology reduces the need for surgeons to turn away from patients to view external monitors, potentially shortening surgery time and reducing radiation exposure.